Tellgen Corporation (300642)

Tellgen Corporation (300642)

$ 10

Foreign Investors Rating

English Version

Date : 15 Jan 2021


Tellgen Corp is a company engaged in research, development, production and sales of in vitro diagnostic reagents and instruments. The Company’s products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner